If you don’t know what to expect, you can’t be ready — especially when it comes to an FDA inspection of your facility. These days, you have to be ready for any kind of inspection: remote, in-person or hybrid.

Don’t let an FDA inspection of your facility throw you into chaos: you need this webinar.

The three presenters — two of whom are former directors within the FDA’s Center for Drug Evaluation and Research (CDER) — will share what you must understand about the FDA’s new remote tools and how to prepare for remote record requests and remote interactive evaluations.

And if you’re one of the many drugmakers that has fallen behind on traditional inspection preparedness during the pandemic, you’ll benefit from their discussion of the risk areas to focus on as you conduct inspection readiness activities.

Cynthia Schnedar, principal of regulatory compliance for Greenleaf Health; Steven J. Lynn, executive vice president of pharmaceuticals for Regulatory Compliance Associates; and Bob Rhoades, managing partner at Validant, will explain how to stay compliant.

Webinar Takeaways:

• Be ready for an FDA inspection of your facility, whether remote or in-person
• Understand the remote tools used by the FDA in a virtual inspection so you can adequately prepare
• Deploy specific inspection-readiness strategies no matter how the FDA decides to carry out an inspection of your facility
• Close gaps in your traditional inspection-readiness activities due to the pandemic
• Evaluate risk areas as you conduct inspection-readiness activities

Get ready for any inspection contingency — and maintain compliance — with the intel you’ll take away from this webinar.